NCT06590818 The Effect of Body Mass Index on Short-term Results of HTO
| NCT ID | NCT06590818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Egymedicalpedia |
| Condition | Osteo Arthritis Knee |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-07-10 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-07-10 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The knee joint plays a major role in weight transmission of the body in day-to-day activities. The biomechanics of the knee and malalignment in lower limb anatomy are major risk factors for chronic knee pain, leaving Total Knee Arthroplasty (TKA) as the best and most successful option for patients with end-stage osteoarthritis (OA)
Eligibility Criteria
Inclusion Criteria: * Meet the diagnostic criteria for knee osteoarthritis and only have one knee * No serious underlying medical disease * Conservative treatment is ineffective and there is a willingness for surgery * X-ray shows degeneration limited to the medial joint space (Ahlback grade ≥ grade II) * Knee flexion range of motion \> 90°, varus deformity \< 15°, flexion contracture \< 5°. * Clinical examination shows intact anterior cruciate ligament and collateral ligament, tenderness point is limited to the medial joint space, and the lateral compartment and patellofemoral joint are intact. Exclusion Criteria: * knee osteoarthritis caused by infection, blood-related or autoimmune diseases. * severe obesity (BMI\>35 kg/m 2 ) or morbid obesity (obesity caused by diseases such as hypercortisolism and hypothyroidism, BMI≥30 kg/m 2 ).
Contact & Investigator
Maysara Abdelhaleem Bayuomy, Assist.Prof
STUDY CHAIR
Orthopedic &Trauma surgery Department, Faculty of medicine, Al-Azhar University, Assiut
Frequently Asked Questions
Who can join the NCT06590818 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Osteo Arthritis Knee. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06590818 currently recruiting?
Yes, NCT06590818 is actively recruiting participants. Contact the research team at addamobil852@gmail.com for enrollment information.
Where is the NCT06590818 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT06590818 clinical trial?
NCT06590818 is sponsored by Egymedicalpedia. The principal investigator is Maysara Abdelhaleem Bayuomy, Assist.Prof at Orthopedic &Trauma surgery Department, Faculty of medicine, Al-Azhar University, Assiut. The trial plans to enroll 50 participants.